We analyzed the expression of five cellular markers and their relation to SIL and cervical cancer development, and found that TOP2A/MCM2 staining is the best biomarker for discriminating between cervical lesion types, followed by p16INK4a, cyclin-E, Ki-67, and telomerase. This evidence concerns the gene MCM2 and cervical carcinoma.